The present invention relates to a method of treating acute lymphoblastic leukemia in a patient in need thereof comprising administering to the patient a therapeutically effective amount of an agent capable of inducing cell death of CCR8 expressing cancer cells. The present invention also relates to a method of diagnosing acute lymphoblastic leukemia in a patient comprising detecting the expression level of CCR8 in a sample obtained from the patient.